🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Tango Therapeutics, Inc.

TNGX Healthcare
$20.24 $-1.38 (-6.38%)
Market Cap: $2.93 B
Gurus Holding
4
Popularity Rank
#2473
% of Shares Held
0.57%
Net Activity (Q1 2026)
-$30.34 M

Guru Ownership Trend

Guru Analysis for Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics, Inc. (TNGX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.65 M.

Top institutional holders include Steven Cohen and Ken Fisher.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $30.34 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who opened a new position. Conversely, Steven Cohen reduced exposure by 73.0%.

Key Holders

Top 5 by Value

$11.17 M
$3.4 M
$2.24 M
$400,346

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$924,454.73
Total Buy Value
New Buys 1
Additions 1
-$31.26 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Tango Therapeutics, Inc. (TNGX)

Major holders include Steven Cohen ($11.17 M), Ken Fisher ($3.4 M), Cliff Asness ($2.24 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 822,759 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $30.34 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited TNGX. The total reported sell value was $31.26 M.

Yes, 1 managers opened new positions in TNGX, and 1 increased their existing holdings. The total reported buy value was $924,454.73.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -73.0% 533,937 $11.17 M Q1 2026
0.00% Reduce -13.5% 162,399 $3.4 M Q1 2026
0.00% Add 30.5% 107,286 $2.24 M Q1 2026
0.00% New Buy 19,137 $400,346 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form